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“People say, “I wish I had more motivation today, because then I would try something.” But our 
thinking is backward. The way our brain works is that dopamine - the so-called feel-good chemical - is 
released the second we actually do something. So the motivation doesn’t come before, it comes after.”
—Brendon Burchard
1. Introduction
Dopamine (DA) (3,4-dihydroxyphenethylamine) is a member of the catecholamine family (a 
monoamine, an organic compound that has a catechol and a side-chain amine) of neurotrans-
mitters in brain and is an antecedent to epinephrine (adrenaline) and norepinephrine (nor-
adrenaline). DA is produced in the body (primarily by nervous tissue and adrenal glands) 
initially by the hydration of the amino acid tyrosine to DOPA by tyrosine hydroxylase and 
further by the decarboxylation of DOPA by aromatic-l-amino-acid decarboxylase. It is a key 
transmitter in the extrapyramidal system of the brain and crucial in synchronizing movement. 
A group of receptors (dopamine receptors) facilitates its function.
DA performs critical role in reward and movement control in the brain. Further, it has a 
function to play in modulation of behavior and cognition; voluntary movement, motivation, 
inhibition of prolactin production, sleep; dreaming; mood; attention; working memory; and 
learning. DA has multiple other functions outside the brain. In blood vessels, it impedes nor-
epinephrine delivery and acts as a vasodilator (at endogenous concentrations); in the kidneys, 
it increases sodium evacuation and urine yield; in the pancreas, it diminishes insulin making; 
in the digestive system, it lessens gastrointestinal motility and guards intestinal mucosa; and 
in the immune system, it diminishes activity of lymphocytes. In the circulation, DA is primar-
ily deposited in and transported by blood platelets [1]. Performing multiple unrelated critical 
biological functions makes this smart chemical, a “VVIP” for sustenance of life both in health 
and disease.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Synthesis, metabolism, and reuptake of dopamine
Tyrosine hydroxylase (TH) is a rate-limiting enzyme in the biosynthesis of DA and other 
catecholamines (Figure 1). Altering expression level of this critical enzyme, which eventu-
ally regulates the synthesis of DA, assists in developing promising therapeutic approaches 
and strategies to promote human health and address disease [2]. In presynaptic neurons, 
Figure 1. Catecholamine biosynthesis (reproduced with approval from Olguin et al. [8]).
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DA is encapsulated into synaptic vesicles and stored (this process is regulated by VMAT2 
(vesicular monoamine transporter 2)). Later, synaptic vesicles release the DA into the syn-
apse. Then, it binds either to presynaptic receptors (the signal can either inhibit (leading 
to inhibit the synthesis and release of neurotransmitters) or excite the cell) or to postsyn-
aptic receptors. Once after the execution of function, DA is taken up into the presynaptic 
cell either by DAT (DA transporter) or by plasma membrane monoamine transporters 
(Figure 2).
Figure 2. Dopamine metabolism (reproduced with approval from Olguin et al. [8]).
Figure 3. Dopamine release and reuptake process (reproduced with approval from Olguin et al. [8]).
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COMT (catechol O-methyl transferase, principally expressed by glial cells) and MAO (has 
two isoforms A and B: monoamine oxidase A, primarily found in catecholaminergic neurons 
(e.g., neurons of substantia nigra) and monoamine oxidase B, chiefly found in astrocytes) are 
two critical enzymes responsible for breakdown of dopamine. COMT breaks down DA to 
3-MT (3-methoxytyramine), which is subsequently reduced to HVA (homovanillic acid) 
by MAO. On the other hand, MAO converts DA to DOPAC (3,4-dihydroxyphenyl ace-
tic acid), which is reduced by COMT to HVA and excreted out through urine (Figure 3). 
Therefore, inhibition of MAO can be a potential therapeutic strategy, which would deceler-
ate the breakdown of DA and confer neuroprotection in neurodegenerative diseases like 
Parkinson’s disease [3].
3. Dopamine: health and disease
DA acts upon to elicit feelings of enjoyment and bolstering, which motivates an animal to 
perform certain tasks repeatedly. In other words, reward system of the brain is strongly asso-
ciated with “feel good” chemical DA. In certain areas of brain such as nucleus accumbens and 
prefrontal cortex, release of dopamine primarily due to fulfilling experiences such as food, 
drugs, physical exercise, sex, learning new tasks, figuring out unknown things, and neural 
stimuli correlated with these actions [4].
Parkinson’s disease (PD) is a degenerative ailment causing tremor and motor impairment and 
is instigated by a loss of dopamine-secreting neurons in an area of the midbrain called sub-
stantia nigra. Dopamine agonists (drugs such as Mirapex (pramipexole), etc.) by mimicking 
dopamine bind and activate dopamine receptors, mirroring the activity of dopamine, leading 
to tricking the brain as if it has dopamine by conferring the biological functions of dopamine. 
Hence, these agonists are used as therapeutic agents in treating depression and Parkinson’s 
disease. Replenishing dopamine levels through l-Dopa improves the PD symptoms, which is 
time-tested therapeutic strategy for PD [5].
There is evidence that schizophrenia comprises distorted levels of dopamine activity [6, 7], 
and most antipsychotic drugs utilized to cure this are DA antagonists, which reduce dopa-
mine activity [8]. Therefore, antagonists have a significant therapeutic value in treating 
psychiatric conditions such as schizophrenia, which result due to overexcited dopamine 
organization. Attention-deficit hyperactivity disorder, bipolar disorder, and addiction are 
also characterized by defects in dopamine production or metabolism [9–12]. When present 
in sufficiently high levels, dopamine can be a neurotoxin (chemical that disorders neural tis-
sue) and a metabotoxin (endogenously produced metabolite that causes adversarial health 
consequences at persistently elevated levels). Chronically high levels of dopamine are linked 
with neuroblastoma, Costello syndrome, leukemia, pheochromocytoma, aromatic L-amino 
acid decarboxylase deficiency, and Menkes disease (MNK). High levels of dopamine can lead 
to hyperactivity, insomnia, agitation and anxiety, depression, delusions, excessive salivation, 
nausea, and digestive problems [9].
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4. Natural ways to boost brain dopamine levels for healthy living
Though DA is available in certain food materials, as it does not cross blood-brain barrier, it 
will not be available in brain. Therefore, other way of enhancing brain dopamine levels in a 
simple way is consuming foods containing the precursor of dopamine, tyrosine that can cross 
blood-brain barrier and enter brain where dopamine will be synthesized from tyrosine.
Foods such as bananas, eggs, avocados, almonds, fish, and chicken are rich in tyrosine. Recent 
studies substantiate the fact that certain bacteria (probiotics) in gut synthesize dopamine and 
influence mood and behavior. Velvet beans (Mucuna pruriens) contain significant levels of 
l-Dopa, the precursor molecule of dopamine, and assist in enhancing brain dopamine levels 
[13]. Studies illustrate that regular exercise [14] and listening to music [15] enhances the brain 
dopamine synthesis and also upregulates the number of dopamine receptors, which eventu-
ally helps for good mood and happy living.
5. Conclusion
The book “Dopamine - Health and Disease” focuses on multiple biological functions of dopa-
mine relating to health and disease. This basic understanding is fundamental in developing 
and implementing therapeutic methods and strategies, which eventually contribute for pro-
moting quality living of mortals. The authors’ contributions lean toward the aspect that by 
taking advantage of fundamental understanding and knowledge relating to dopamine per se 
and its biological functions, how efforts can be made to translate the discoveries/innovations 
to promote human well-being, rather than from the perspective of hard-core scientific paper. 
Reader would appreciate this perspective as it directly influences the value of our lives.
Therefore, the very nature and purpose of the present endeavor aims at understanding the funda-
mental knowledge relating to dopamine and applying the same for supporting human life, which 
is very essence of biomedical research. At the same time, it is essential to realize the basic fact that 
practice of balanced lifestyle, meaning moderate consumption of food along with good physico-
mental (Yoga, Dahn, Shinshin-Toitsu-Do, etc.) and recreational activities, as practiced in ancient 
civilizations, can sustain the optimum levels of neurotransmitters and hormones and promote 
happy living. Here comes the importance of traditional/indigenous practices and knowledge of 
multiple age-old civilizations in promoting human health. The contents of this book fulfill the aim 
with which this project is initiated and moved on and successfully brought to a shape.
Acknowledgements
This work is supported by funding from Department of Biotechnology (DBT), India, grant num-
bers (BT/405/NE/U-Excel/2013 and BT/PR16868/NER/95/328/2015), and DST-SERB (Department 
Introductory Chapter: “Feel Good” Chemical Dopamine - Role in Health and Disease
http://dx.doi.org/10.5772/intechopen.81451
7
of Science and Technology-Science and Engineering Research Board), India, grant number 
(EMR/2016/002375).
Author details
Sarat Chandra Yenisetti
Address all correspondence to: yschandrays@rediffmail.com
Drosophila Neurobiology Laboratory, Department of Zoology, Nagaland University 
(Central), Lumami, Nagaland, India
References
[1] Calabresi P, Picconi B, Tozzi A, Di Fillippo M. Dopamine-mediated regulation of cortico-
striatal synaptic plasticity. Trends in Neurosciences. 2007;30(5):211-219
[2] Tolleson C, Classen D. The function of tyrosine hydroxylase in the normal and Par-
kinsonian brain. CNS and Neurological Disorders-Drug Targets. 2012;11(4):381-386
[3] Mousseau DD, Baker GB. Recent developments in the regulation of monoamine oxidase 
form and function: Is the current model restricting our understanding of the breadth of 
contribution of monoamine oxidase to brain dysfunction? Current Topics in Medicinal 
Chemistry. 2012;12(20):2163-2176
[4] Maas JW, Bowden CL, Miller AL, et al. Schizophrenia, psychosis, and cerebrospinal 
fluid homovanillic acid concentrations. Schizophrenia Bulletin. 1997;23(1):147-154
[5] DeMaagd G, Phillip A. Parkinson’s disease and its management. Part 5: Treatment of 
nonmotor complications. Pharmacy and Therapeutics. 2015;40(12):838-842
[6] Leruelle M, Abi-Dargham A, van Dyck CH. Single photon emission computerized 
tomography imaging of amphetamine induced dopamine release in drug-free schizo-
phrenic subjects. Proceedings of National Academy of Sciences, USA. 1996;93:9235-9240
[7] Jones HM, Pilowsky LS. Dopamine and antipsychotic drug action revisited. Brazilian 
Journal of Psychiatry. 2002;181:271-275
[8] Olguin HJ, Guzman DG, Garcia EH, Mejia GB. The role of dopamine and its function 
as a consequence of oxidative stress. Oxidative Medicine and Cellular Longevity. 2016; 
9(730):467
[9] Schildkraut JJ. The catecholamine hypothesis of affective disorders: A review of sup-
portive evidence. American Journal of Psychiatry. 1965;122:509-522
[10] Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, et al. Toward a bio-
chemical classification of depressive disorders. I. Differences in urinary excretion of 
Dopamine - Health and Disease8
MHPG and other catecholamine metabolites in clinically defined subtypes of depres-
sion. Archives of General Psychiatry. 1978;35:1427-1433
[11] Wise RA. Addictive drugs and brain stimulation reward. Annual Review of Neuroscience. 
1996;19:319-340
[12] Cook EH, Stein MA, Krasowski MD. Association of attention-deficit disorder and the 
dopamine transporter gene. American Journal of Human Genetics. 1995;56:993-998
[13] Lampariello LR, Cortelazzo A, Guerranti R, Sticozzi C, Valacchi G. The magic velvet 
bean of Mucuna pruriens. Jouranl of Traditional and Complementary Medicine. 2012; 
2(4):331-339
[14] Greenwood BN. The role of dopamine in overcoming aversion with exercise. Brain 
Research. 2018. pii: S0006-8993(18)30452-9. In Press
[15] Salimpoor VN, Benovoy M, Larcher K, Dagher A, Zatorre RJ. Anatomically distinct 
dopamine release during anticipation and experience of peak emotion to music. Nature 
Neuroscience. 2011;14(2):257-262
Introductory Chapter: “Feel Good” Chemical Dopamine - Role in Health and Disease
http://dx.doi.org/10.5772/intechopen.81451
9

